Polyethylenimine-associated cerium oxide nanoparticles: A novel promising gene delivery vector.

AIMS

The development of highly efficient and low toxic non-viral gene delivery vectors is the most challenging issues for successful application of gene therapy. A particular focus has been on understanding structure-activity relationships for transfection activity and toxicity of polyethylenimine (PEI). During the last decade, the use of cerium oxide nanoparticles (CeO-NPs) in biomedicine has attracted much attention due to their pH-dependent antioxidant activity. CeO-NPs provide protection normal cells from various forms of reactive oxygen species, but possess innate cytotoxicity and apoptosis to cancer cells. The purpose of this study was to design a new class of gene carriers by low molecular weight PEI (B-PEI 10 kDa) coordination onto CeO-NPs.

MAIN METHODS

B-PEI 10 kDa was conjugated to CeO-NPs by Epichlorohydrin linker. Transfection efficiency, cytotoxic and apoptotic effects of pDNA-PEI-CeO NPs were evaluated on WEHI 164 cancer cells and normal L929 cells lines.

KEY FINDINGS

PEI-CeO NPs was able to condense the pDNA at carrier/plasmid (C/P) weight ratios of 0.5. The size and zeta potential of pDNA-PEI-CeO NPs were 124 ± 7 nm and 22 ± 2 mV, respectively. The transfection efficacy of synthesized pDNA-PEI-CeO NPs improved and the cytotoxicity was decreased compared to pDNA-PEI. Moreover, pDNA-PEI-CeO NPs induced more apoptosis than unmodified PEI and CeO-NPs control groups. pDNA-PEI-CeO NPs displayed more transfection, cytotoxicity, and apoptosis in WEHI 164 cancer cells than normal L929 cells.

SIGNIFICANCE

In conclusion, PEI-CeO nanocarriers could act as a potential candidate for gene and drug delivery to cancerous and tumor cells.